首頁 >產品介紹>免疫實驗相關試劑耗材>試劑-小分子重組抗體>Creative Biolabs 小分子重組抗體
免疫實驗相關試劑耗材
| Item Name | Target |
| Adalimumab: Anti-Human TNF Therapeutic Antibody (Humira) | TNF |
| Anti-ANGPT2 Therapeutic Antibody | ANGPT2 |
| Anti-APP Therapeutic Antibody (BAN2401) | APP |
| Anti-CD19 Therapeutic Antibody (Blinatumomab) | CD-19 |
| Anti-CD19 Therapeutic Antibody (Blinatumomab) | CD3 CD19 |
| Anti-CD19 Therapeutic Antibody (Blinatumomab) | CD19 |
| Anti-CD20 Therapeutic Antibody (ocaratuzumab) | CD20 |
| Anti-Cd274 VHH Single Domain Antibody | Cd274 |
| Anti-CEA scFv | CEA |
| Anti-CSF3R Therapeutic Antibody | CSF3R |
| Anti-DHFR VHH Single Domain Antibody | DHFR |
| Anti-EGFR Therapeutic Antibody (ABT-806) | EGFR |
| Anti-EGFR Therapeutic Antibody (THERACIM) | EGFR |
| Anti-FCGR2B Therapeutic Antibody (SM201) | FCGR2B |
| Anti-GPNMB Therapeutic Antibody (glembatumumab) | GPNMB |
| Anti-Human 5T4 therapeutic Antibody Fab Fragment, 5T4 (Naptumomab estafenatox) | 5T4 |
| Anti-Human C5 Therapeutic Antibody (Soliris) Eculizumab | Human C5 |
| Anti-Human CD3 Therapeutic Antibody (Orthoclone OKT3 | CD3 |
| Anti-Human CD30 Therapeutic Antibody (Iratumumab) | CD30 |
| Anti-Human CD38 Therapeutic Antibody (Daratumumab) | CD38 |
| Anti-Human CTLA4 Therapeutic Antibody (Yervoy) Ipilimumab | CTLA4 |
| Anti-Human DR5 Therapeutic Antibody (Conatumumab) | DR5 |
| Anti-Human ErbB2 Therapeutic Antibody (Herceptin) | Her3 |
| Anti-Human ERBB2 Therapeutic Antibody (trastuzumab emtansine | ERBB2 |
| Anti-Human ERBB3 Therapeutic Antibody (Patritumab) | ERBB3 |
| Anti-Human IL6 Therapeutic Antibody (Sirukumab) | IL6 |
| Anti-Human interferon α/β receptor Therapeutic Antibody | IFNAR |
| Anti-Human Lewis Y Therapeutic Antibody (MB 311) | Lewis Y |
| Anti-Human MUC16 Therapeutic Antibody (sofituzumab vedotin) | MUC16 |
| Anti-Human PDCD1 Therapeutic Antibody | PDCD1 |
| Anti-Human scleroscin Therapeutic Antibody (Romosozumab | scleroscin |
| Anti-Human SLAMF7 Therapeutic Antibody (PDL241) | SLAMF7 |
| Anti-Human VEGF Therapeutic Antibody (Bevacizumab) | VEGF |
| Anti-IL4R Therapeutic Antibody | IL4R |
| Anti-LILRB4 Therapeutic Antibody (TRX385) | LILRB4 |
| Anti-MMP9 Therapeutic Antibody (GS-5745) | MMP9 |
| Anti-PDCD1 Therapeutic Antibody (OPDIVO) | PDCD1 |
| Anti-RSV glycoprotein F Therapeutic Antibody (NUMAX), Motavizumab | RSV glycoprotein F |
| Anti-SLAMF7 Therapeutic Antibody (elotuzumab) | SLAMF7 |
| Anti-TGFB1 Therapeutic Antibody (metelimumab) | TGFB1 |
| Anti-TNFRSF21 Therapeutic Antibody (DQM3) | TNFRSF21 |
| CH2 domain anti-ERBB2 | Human Her2 |
| CH2 domain scaffold protein anti-Human Her2 | Her2 |
| Fc fragment scaffold protein anti-Human Her2 | Her2 |
| Goat Anti-Mouse IgG Antibody, FITC conjugated | Mouse IgG |
| Ipilimumab: Anti-Human CTLA4 Therapeutic Antibody (Yervoy) | CTLA4 |
| Labetuzumab: Anti-Human CEACAM5 Therapeutic Antibody (CEA-Cide) | CEACAM5 |
| Obinutuzumab | MS4A1 |
| Rabbit Anti-T7 RNA Polymerase Antibody | T7 |
| Recombinant Anti-Ampicillin Antibody Fab Fragment | Ampicillin |
| Recombinant Anti-AXL Antibody | AXL |
| Recombinant Anti-CD33 Antibody | CD33 |
| Recombinant Anti-ErbB2 Antibody (2C4(Pertuzumab) | ErbB2 |
| Recombinant Anti-Gliadin Antibody | Gliadin |
| Recombinant Anti-Human CD33 Antibody scFv | CD33 |
| Recombinant Anti-Human CTLA4 Antibody | CTLA4 |
| Recombinant Anti-Human CTLA4 Antibody Fab Fragment | CTLA4 |
| Recombinant Anti-Human ERBB2 Antibody Fab Fragment | ERBB2 |
| Recombinant Anti-Human LAG3 Antibody | LAG3 |
| Recombinant Anti-Human S1P Antibod | S1P |
| Recombinant Anti-human TNF VHH Single Domain Antibody | TNF |
| Recombinant Anti-IgG Ch1 Domain Antibody | IgG CH1 |
| Recombinant Anti-P. aeruginosa psl Antibody | P. aeruginosa psl |
| Recombinant Anti-S. aureus ClfA Antibody scFv Fragment | S. aureus ClfA |
| Recombinant anti-Tau antibody | Tau |
| Recombinant anti-VEGFA single domain antibody | VEGFA |
| Recombinant Human Anti-fibronectin ED-A Antibody | ED-A |
| Recombinant Human Anti-HBV PreS2 Antibody | HBV PreS2 |
| Recombinant Human Anti-HIV-1 gp41 Antibody (2F5 ) | HIV-1 gp41 |
| Recombinant Human Anti-Human XCR1 Monoclonal Antibody | XCR1 |
| Recombinant Human Anti-RSV Antibody (AM14) | RSV |
| Recombinant Human Anti-Siglec-15 Antibody | Siglec-15 |
| Recombinant humanized antibody to CFD (Lampalizumab IgG full length) | CFD |
| Recombinant monoclonal antibody to ACVR2B (Bimagrumab) | ACVR2B |
| Recombinant monoclonal antibody to APP (Aducanumab) | APP |
| Recombinant monoclonal antibody to CCR4 (Mogamulizumab) | CCR4 |
| Recombinant monoclonal antibody to Human CD20 (Tositumomab) | CD20 |
| Recombinant monoclonal antibody to integrin alpha 4 beta 7 (Etrolizumab) | integrin alpha 4 beta 7 |
| Recombinant Mouse Anti-AAV 2 Antibody | AAV2 |
| Recombinant Mouse Anti-D. melanogaster DAT Antibody (9D5) | D. melanogaster DAT |
| Tregallzumab | CD4 |